MedTrace Logo

Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development

NCT03775902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-07-06

No results posted yet for this study

Summary

To investigate the role of ATP sensitive K+ potassium channels and the Na+/K+ pump in the development of fatigue in healthy and in insulin resistant subjects.

Conditions

Interventions

DRUG

Placebo

placebo tablet

DRUG

Nicorandil

20 mg nicorandil (Ikorel, Sanofi Winthrop Industrie; NIC)

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-19
Primary Completion
2020-01-01
Completion
2020-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03775902 on ClinicalTrials.gov